Target type: molecularfunction
Binding to a microRNA, a 21-23 nucleotide RNA that is processed from a stem-loop RNA precursor (pre-miRNA) that is encoded within plant and animal genomes. [PMID:15066283]
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play a critical role in regulating gene expression. They exert their regulatory function primarily by binding to specific target messenger RNA (mRNA) molecules, typically in the 3' untranslated region (3'UTR), leading to post-transcriptional gene silencing. This binding event can occur through complementary base pairing between the miRNA and the mRNA sequence, resulting in various outcomes:
1. **mRNA Degradation:** Binding of the miRNA to the mRNA can trigger the recruitment of the RNA-induced silencing complex (RISC), which contains proteins like Argonaute. This complex can then degrade the target mRNA, preventing its translation into a protein.
2. **Translation Inhibition:** Even if the mRNA is not degraded, the miRNA-mRNA interaction can hinder ribosome recruitment and prevent the mRNA from being translated into a protein.
3. **mRNA Storage:** In certain cases, miRNA binding might lead to the sequestration of the mRNA in processing bodies (P-bodies) or other cellular compartments, effectively preventing its translation.
4. **Epigenetic Modifications:** Recent evidence suggests that miRNAs can also induce epigenetic modifications, such as histone modifications, affecting gene expression at the chromatin level.
The specific molecular function of miRNA binding depends on various factors:
* **Seed Sequence:** The miRNA's seed sequence, a 6-8 nucleotide region at the 5' end, is crucial for target recognition. This seed sequence has a high affinity for the target mRNA and is often perfectly complementary.
* **Target Site Accessibility:** The accessibility of the target site within the mRNA can influence miRNA binding efficiency. Secondary structures within the mRNA, such as stem-loops, can hinder miRNA binding.
* **Cellular Context:** The cellular context, including the presence of specific proteins and other regulatory molecules, can influence miRNA-mRNA interactions.
The regulation of gene expression by miRNAs is highly dynamic and complex. These small molecules play a crucial role in various biological processes, including development, differentiation, cell growth, and disease pathogenesis.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein argonaute-2 | A protein argonaute-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UKV8] | Homo sapiens (human) |
ELAV-like protein 1 | An ELAV-like protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15717] | Homo sapiens (human) |
RISC-loading complex subunit TARBP2 | A RISC-loading complex subunit TARBP2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15633] | Homo sapiens (human) |
Heterogeneous nuclear ribonucleoprotein A1 | A heterogeneous nuclear ribonucleoprotein A1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P09651] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
enoxacin | enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea. Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID. | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
sulfaguanidine | sulfaguanidine : A sulfonamide incorporating a guanidine moiety used to block the synthesis of folic acid; mostly used in veterinary medicine Sulfaguanidine: A sulfanilamide antimicrobial agent that is used to treat enteric infections. | sulfonamide antibiotic | antiinfective agent |
sulfanilamide | substituted aniline; sulfonamide; sulfonamide antibiotic | antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor | |
sulfisomidine | sulfisomidine : A sulfonamide consisting of pyrimidine having methyl substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. Sulfisomidine: A sulfanilamide antibacterial agent. | pyrimidines; sulfonamide; sulfonamide antibiotic | antiinfective agent |
uridine monophosphate | uridine 5'-monophosphate : A pyrimidine ribonucleoside 5'-monophosphate having uracil as the nucleobase. Uridine Monophosphate: 5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. | pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite |
camptothecin | NSC 100880: carboxylate (opened lactone) form of camptothecin; RN refers to (S)-isomer; structure given in first source | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
schisanhenol b | schisanhenol B: isolated from kernels of Schisandra rubriflora; structure given in first source | ||
5,8-dihydroxy-3-methyl-4-(9h)-naphtho(2,3-c)furanone | 5,8-dihydroxy-3-methyl-4-(9H)-naphtho(2,3-c)furanone: isolated from Micromonospora sp. KY7123; structure given in first source | ||
quercetin | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger | |
Dihydrotanshinone I | dihydrotanshinone I: extracted from Radix Salviae | abietane diterpenoid | anticoronaviral agent |